{
    "organizations": [],
    "uuid": "17561c6235d172fbef02ffa68f003f08455a3791",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-regulus-qtrly-net-loss-per-share-0/brief-regulus-qtrly-net-loss-per-share-0-14-idUSASB0C9A7",
    "ord_in_thread": 0,
    "title": "BRIEF-Regulus Qtrly Net Loss Per Share $0.14",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Regulus Therapeutics Inc:\n* REGULUS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PIPELINE UPDATE\n* REGULUS THERAPEUTICS INC - QTRLY NET LOSS PER SHARE $0.14 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T05:26:00.000+02:00",
    "crawled": "2018-03-08T17:05:20.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "regulus",
        "therapeutic",
        "inc",
        "regulus",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "pipeline",
        "update",
        "regulus",
        "therapeutic",
        "inc",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}